FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) CEO Raza Bokhari talks to Proactive about the group's upcoming shareholder meeting on May 14, intended to address shareholder concerns.
What's more, Bokhari says the company has formed a license agreement with Innovet Italia SRL to develop FDA-approved veterinary drugs for the treatment of gastrointestinal diseases in dogs and cats.